WASHINGTON, Sept. 5, 2024 /PRNewswire/ — EARTHDAY.ORG (EDO), the global organizer of Earth Day, observed annually on April 22, announces the global theme for Earth Day 2025: Our Power, Our Planet. 2025 marks the 55th anniversary of EARTH DAY, and to honor this milestone, we are inviting our one billion supporters in 192 countries to […]
Category Archives: Pr Newswire
Pr Newswire
Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
05
Sep
Sep
HUNTSVILLE, Sept. 04, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced that Steve Ledger, Interim Chief Executive Officer of Serina, will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024, at 12:00 p.m. ET. […]
TOKYO and SALT LAKE CITY, Sept. 5, 2024 /PRNewswire/ — Strider Technologies, Inc. the leading provider of strategic intelligence, today announced it has officially completed incorporation of its Japan subsidiary, Strider Technologies Japan KK, and opened its Tokyo office to further support the expansion of its economic security solutions in Japan, the company’s fastest growing international […]
MILPITAS, Calif., Sept. 4, 2024 /PRNewswire/ — Global semiconductor equipment billings increased 4% year-over-year to US$26.8 billion in the second quarter of 2024, while quarter-over-quarter billings edged up 1% during the same period, SEMI announced today in its Worldwide Semiconductor Equipment Market Statistics (WWSEMS) Report. Semiconductor Equipment Billings by Region for 2Q 2024 SEMI WWSEMS Report […]
SYDNEY, Sept. 5, 2024 /PRNewswire/ — Unpopular but effective road safety solutions such as speed management initiatives are urgently needed if Australia and other countries are to halve road fatalities by 2030, according to industry insights contained in a global road safety report released today. In the three years since Australia aligned its road safety […]
GUANGZHOU, China, Sept. 5, 2024 /PRNewswire/ — HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game live streaming platform in China, today announced that Mr. Raymond Peng Lei has been appointed by the Company’s board of directors (the “Board”) to serve as Acting Co-Chief Executive Officer (“Acting Co-CEO”) and Chief Financial Officer of […]
WILMINGTON, Del., Sept. 5, 2024 /PRNewswire/ — Thunder Power Holdings, Inc. (Nasdaq: AIEV) (“Thunder Power” or the “Company”), a technology innovator and a developer of premium passenger EVs, today announced its unaudited financial results for the three months ended June 30, 2024 (“Second Quarter 2024”). Second Quarter 2024 Financial Highlights Revenues were nil, consistent with the same period […]
Pr Newswire
Creyon Bio Granted Second U.S. Patent for AI/Machine Learning-Enabled Oligonucleotide-Based Medicine Engineering Platform
04
Sep
Sep
Patent protects Creyon™ Platform’s proprietary method for rapid engineering and optimization of therapeutic oligonucleotides with AI/ML, accelerating development timelines Recent publication details innovative algorithms for efficient design of oligonucleotide-based medicines SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) — Creyon Bio, Inc. (“Creyon”), a clinical-stage leader in AI/machine learning-enabled engineering of […]
Pr Newswire
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
04
Sep
Sep
WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference on Tuesday, September 10, 2024, at 10:00 a.m. ET. The […]
Pr Newswire
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
04
Sep
Sep
ZURICH and ZUG, Switzerland and STOCKHOLM, Sept. 04, 2024 (GLOBE NEWSWIRE) — Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Veld Pharmaceuticals GmbH (“Veld”) and Slavpharma GmbH (“Slavpharma”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in Africa and Eurasia. Under the terms of this exclusive agreement, […]